Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2374-4677
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy ; volume:8 ; number:1 ; day:28 ; month:12 ; year:2022 ; pages:1-2 ; date:12.2022
npj Breast cancer ; 8, Heft 1 (28.12.2022), 1-2, 12.2022
- Creator
-
Gharbi, Severine Isabelle
Pelletier, Laura A.
Espada, Alfonso
Gutiérrez, Jesus
Sanfeliciano, Sonia Maria Gutiérrez
Rauch, Charles T.
Ganado, Maria Patricia
Baquero, Carmen
Zapatero, Elisabet
Zhang, Aiping
Benach, Jordi
Russell, Anna-Maria
Cano, Leticia
Gomez, Sandra
Broughton, Howard
Pulliam, Nicholas
Perez, Carmen Maria
Torres, Raquel
Debets, Marjoke F.
de Dios, Alfonso
Puig, Oscar
Hilgers, Mark T.
Lallena, Maria Jose
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41523-022-00503-0
- URN
-
urn:nbn:de:101:1-2023030921253688822124
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gharbi, Severine Isabelle
- Pelletier, Laura A.
- Espada, Alfonso
- Gutiérrez, Jesus
- Sanfeliciano, Sonia Maria Gutiérrez
- Rauch, Charles T.
- Ganado, Maria Patricia
- Baquero, Carmen
- Zapatero, Elisabet
- Zhang, Aiping
- Benach, Jordi
- Russell, Anna-Maria
- Cano, Leticia
- Gomez, Sandra
- Broughton, Howard
- Pulliam, Nicholas
- Perez, Carmen Maria
- Torres, Raquel
- Debets, Marjoke F.
- de Dios, Alfonso
- Puig, Oscar
- Hilgers, Mark T.
- Lallena, Maria Jose
- SpringerLink (Online service)
Other Objects (12)
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
Regulation of CDK4
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
Regulation of CDK4
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells
Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
The Drosophila Cyclin D-Cdk4 complex promotes cellular growth
Cyclin D1—Cdk4 regulates neuronal activity through phosphorylation of GABAA receptors
Efficient Wnt mediated intestinal hyperproliferation requires the cyclin D2-CDK4/6 complex
The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary
Regulation of CDK4
The HTLV-1 Tax protein binding domain of cyclin-dependent kinase 4 (CDK4) includes the regulatory PSTAIRE helix
LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancer
Novel functions of aberrant cyclin D1/CDK4 activity in mantle cell lymphoma and consequences for proteasome inhibitor treatment
Anti-cancer activity of Psoralea fructus through the downregulation of cyclin D1 and CDK4 in human colorectal cancer cells